Diagnostic utility of anchored multiplex polymerase chain reaction‐based fusion assay on sacrificed cytology slides
Cancer Cytopathology · 2026-06 · 134 (6)
DOI: 10.1002/cncy.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 12.05.2026. Verfasst von Charlotte I Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Multiplex Polymerase Chain Reaction, Salivary Gland Neoplasms, Cytodiagnosis, Gene Fusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
Gene fusion testing, essential for the diagnosis and classification of many salivary gland and soft tissue neoplasms, is typically performed on formalin‐fixed paraffin‐embedded material, which may be limited or unavailable in cytology specimens. Although cytology smears have been validated for single‐gene and DNA‐based assays, evidence supporting routine diagnostic use of RNA‐based next‐generation sequencing fusion testing on smears remains limited.
Methods
The authors evaluated the clinical utility of a clinically validated anchored multiplex polymerase chain reaction (adenosine monophosphate)–based RNA fusion assay performed on digitized, scraped, and sacrificed cytology smears. Alcohol‐fixed Papanicolaou‐stained and air‐dried modified Giemsa‐stained smears meeting predefined cellularity thresholds were digitally archived, manually scraped, and processed for RNA extraction. Fusion testing targeted solid tumor–associated genes, and sequencing was performed on an Illumina platform.
Results
Of 8706 fusion assays performed during the study period, 807 (9.3%) were applied to cytology specimens, including 14 cases (1.7%) using sacrificed direct smears. Adequate nucleic acid was obtained in all cases. Gene fusions were detected in 64% (9/14), including MYB::NFIB , ACTB::PLAG1 , NCALD::PLAG1 , CRTC1::MAML2 , COL1A1::PDGFB , COL1A2::USP6 , and FGFR1::NOL4 . Fusion results enabled definitive diagnosis for adenoid cystic carcinoma, mucoepidermoid carcinoma, pleomorphic adenoma, nodular fasciitis, and dermatofibrosarcoma protuberans.
Conclusions
Adenosine monophosphate‐based RNA fusion testing on sacrificed cytology smears is feasible, reliable, and diagnostically impactful, expanding the role of cytology specimens in definitive tumor classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Charlotte I Wang, M Lisa Zhang, Emilio Madrigal, William C Faquin
Zitieren
APA
Wang, C. I., Zhang, M. L., Madrigal, E., Faquin, W. C., & Chebib, I. (2026). Diagnostic utility of anchored multiplex polymerase chain reaction‐based fusion assay on sacrificed cytology slides. Cancer Cytopathology, 134(6). https://doi.org/10.1002/cncy.70105
Vancouver
Wang CI, Zhang ML, Madrigal E, Faquin WC, Chebib I. Diagnostic utility of anchored multiplex polymerase chain reaction‐based fusion assay on sacrificed cytology slides. Cancer Cytopathology. 2026;134(6). doi:10.1002/cncy.70105
BibTeX
@article{Wang2026,
author = {Wang, Charlotte I and Zhang, M Lisa and Madrigal, Emilio and Faquin, William C and Chebib, Ivan},
title = {Diagnostic utility of anchored multiplex polymerase chain reaction‐based fusion assay on sacrificed cytology slides},
journal = {Cancer Cytopathology},
year = {2026},
volume = {134},
number = {6},
doi = {10.1002/cncy.70105}
}
EUVIMED